Diabetic patients are prone to coronary heart disease such as myocardial infarction, angina pectoris, and symptoms such as hypoglycemia and high blood sugar levels. In particular, during the onset of acute coronary syndrome (ACS) such as myocardial infarction and unstable angina, these symptoms have a great influence on the prognosis of blood vessels. Therefore, in addition to the treatment of coronary artery, these patients must also be controlled simultaneously. Good blood sugar. However, the mechanism of influence of blood glucose changes on prognosis is currently unclear, and naturally there is no reliable treatment.
Saga University's research team targeted 39 patients with type 2 diabetes mellitus (T2DM) who were concurrent with ACS, with α-glucose blockers (α-GI) on blood glucose instability, arrhythmia, and self-discipline in the acute phase of ACS The therapeutic effects of neurological disorders were analyzed. These patients were randomly assigned to form 19 patients in the experimental group and 20 in the control group. During the course of the experiment, in addition to dynamic blood glucose monitoring for all personnel, Holter was also used to record their ECG for a period of two days.
The experimental group started taking the α-glucose blocker miglitol at the 25th hour and found that the incidence of high hypoglycemia (≤4.44 mmo/L) was observed in both groups on the first day (control group). 35%, test group 31%). On the second day, the blood glucose fluctuations in the test group decreased, the incidence of hypoglycemia fell to 7.7%, and the lowest value of blood glucose increased. In addition, Holter showed that the mean heart rate and maximum heart rate of the control group and the mean arrhythmia index LF/HF increased on the second day; the above indicators of the test group were improved by taking miglitol.
Alpha-glucose blockers are drugs that control postprandial blood glucose by slowing the absorption of sugar in the small intestine and are currently widely used. (Technology Department)
Medical Cold Patch
Throat Pain Relief Patch
[Name] Medical Cold Patch
[Package Dimension] 36 round pieces
The pain relief patch is composed of three layers, namely, backing lining, middle gel and protective film. It is free from pharmacological, immunological or metabolic ingredients.
[Scope of Application] For cold physiotherapy, closed soft tissue only.
[Indications]
The patches give fast acting pain relief for acute and chronic tonsillitis.
[How To Use a Patch]
Please follow the Schematic Diagram. One piece, one time.
The curing effect of each piece can last for 6-8 hours.
[Attention]
Do not apply the patch on the problematic skin, such as wounds, eczema, dermatitis,or in the eyes. People allergic to herbs and the pregnant are advised not to use the medication. If swelling or irritation occurs, please stop using and if any of these effects persist or worsen.notify your doctor or pharmacist promptly. Children using the patch must be supervised by adults.
[Storage Conditions] Store below 30c in a dry place away from heat and direct sunlight.
Throat Pain Relief Patch,Throat Pain Relief Pad,Throat Pain Relief Plaster,Antitussive Patch
Shandong XiJieYiTong International Trade Co.,Ltd. , https://www.xijieyitongpatches.com